Polymer Capital Management (Us) LLC Exact Sciences Corp Transaction History
Polymer Capital Management (Us) LLC
- $846 Billion
- Q2 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 5,076 shares of EXAS stock, worth $307,504. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,076Holding current value
$307,504% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
649Shares Held
157MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$1.1 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$731 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$727 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$326 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...